Mark Johnson - Concepedia

Author

Mark Johnson

St. Jude Children's Research Hospital ORCID

Also Known As

Johnson, Mark A., M A Johnson, M Johnson, M. A. Johnson, M. Johnson, M.A. Johnson, M. A. Johnson, MARK A. JOHNSON, Mark A Johnson, Mark A. Johnson

104

Publications

4.5K

Citations

H-Index

195

Concepts

All Affiliations

St. Jude Children's Research Hospital Illinois College University of Illinois Urbana-Champaign Newcastle University National Cancer Institute

About

Mark Johnson is an author at St. Jude Children's Research Hospital specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.7K
2	Engineering	10	10	560
3	Health Sciences	6	6	572
4	Business	3	3	165
5	Management	2	2	40

Mark Johnson

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
The epidemiology of pathogenic mitochondrial DNA mutations Patrick F. Chinnery, Mark Johnson, T. M. Wardell, Annals of Neurology Genetic TestingNeurological DisorderGeneticsGenetic EpidemiologyPathology	2000	325
Data on fibre size in thirty-six human muscles J. P. Polgár, Mark Johnson, David R. Appleton Journal of the Neurological Sciences Muscle FunctionKinesiologySkeletal MusclePhysiologyBiomechanics	1973	312
Pharmacokinetics and Antiretroviral Activity of Lamivudine Alone or When Coadministered with Zidovudine in Human Immunodeficiency Virus Type 1–Infected Pregnant Women and Their Offspring Jagidesa Moodley, Dhayendre Moodley, Kubendran Pillay, The Journal of Infectious Diseases Drug InteractionsHiv-1 RnaAntiretroviral ActivityTreatment And PreventionNeurovirology	1998	189
Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells. Mark Johnson, Arnold Fridland Molecular Pharmacology	1989	178
A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism Mark T. Boyd, Guy R. Simpson, Alan J. Cann, Journal of Virology Viral ReplicationImmunologyMolecular BiologySingle Point MutationViral Structural Protein	1993	152
Development of a simulation model of biomass supply chain for biofuel production Fengli Zhang, Dana M. Johnson, Mark Johnson Renewable Energy Simulation ModelSupply Chain OptimizationBiomass ConversionBiofuel ProductionBioenergy	2012	125
Influence of electrical stimulation of the tibialis anterior muscle in paraplegic subjects. 2. Morphological and histochemical properties Lynn Rochester, Martin Barron, Colin Chandler, Spinal Cord Electrical StimulationParaplegic SubjectsMuscle InjuryMuscle FunctionNeurophysiology	1995	123
Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells. Mark Johnson, Gurpreet S. Ahluwalia, Michele Connelly, Journal of Biological Chemistry Adenosine KinaseAdenosine Kinase ActivityImmunologyAntiviral DrugHuman Immunodeficiency Virus	1988	122
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity David A. Cooney, Gurpreet S. Ahluwalia, Hiroaki Mitsuya, Biochemical Pharmacology MedicineHtlv-iii InfectivityAntiviral Drug DevelopmentAntiviral ResponseAntiviral Therapy	1987	102
Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study David Mutimer, Nicolai Naoumov, Pieter Honkoop, Journal of Hepatology HepatologyViral HepatitisLamivudine TherapyImmunologyHepatitis B	1998	100

Page 1